DANAHER CORP

DHR is the ticker symbol for Danaher Corporation, a global company that designs, manufactures, and markets medical, industrial, and commercial products and services. The stock trades on the New York Stock Exchange. Danaher operates through segments including biotechnology, life sciences, and diagnostics, serving customers in healthcare, research, and industrial markets worldwide.

Danaher operates primarily in the life sciences and diagnostics industry, with additional exposure to environmental and applied solutions. The company provides instruments, consumables, and services used in research, clinical diagnostics, and industrial applications. Its business spans biotechnology, medical devices, and water quality analysis, positioning it within the broader healthcare and industrial technology sectors.

Recent performance for DHR can be found in the stock price section of this page, which displays the latest price, daily change, and historical chart. Performance varies with market conditions, earnings reports, and sector trends. For the most current data, refer to the live quote and performance metrics provided above.

Common valuation metrics for DHR include the price-to-earnings (P/E) ratio, price-to-sales (P/S), and enterprise value-to-EBITDA (EV/EBITDA). These help assess how the market values Danaher relative to its earnings, revenue, and cash flow. Comparing these metrics to peers and historical averages provides context. Current valuation data is available on this page.

Yes, Danaher pays a regular quarterly dividend to shareholders. The dividend amount and yield are displayed in the dividend section of this page. Investors can review the dividend history and payout ratio to understand how much of earnings are returned. For the latest dividend details, check the current data shown above.

Risks for DHR include economic downturns that reduce demand for its products, regulatory changes affecting healthcare and industrial markets, and competition. Additionally, currency fluctuations and interest rate movements can impact financial results. The company's global operations expose it to geopolitical and supply chain risks. Investors should review the risk factors in Danaher's SEC filings for a comprehensive list.